(0.12%) 5 303.27 points
(0.34%) 40 004 points
(-0.07%) 16 686 points
(0.97%) $80.00
(5.73%) $2.64
(1.44%) $2 419.80
(6.36%) $31.78
(2.18%) $1 094.70
(-0.02%) $0.920
(-0.18%) $10.68
(-0.27%) $0.787
(0.19%) $91.05
Live Chart Being Loaded With Signals
ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases...
Stats | |
---|---|
Today's Volume | 95 722.00 |
Average Volume | 413 479 |
Market Cap | 3.75M |
EPS | $0 ( 2024-05-17 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0.0410 (0.91%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-05-10 | Incon Co., Ltd. | Buy | 0 | |
2023-01-26 | Guzman Pablo A. | Buy | 100 000 | Stock Options (right to buy) |
2022-12-12 | Guzman Pablo A. | Sell | 9 015 | Warrant (Right to Buy) |
2023-01-26 | Guzman Pablo A. | Sell | 0 | Common Stock |
2023-01-05 | Sapirstein James | Buy | 0 |
INSIDER POWER |
---|
99.68 |
Last 73 transactions |
Buy: 5 985 759 | Sell: 1 615 903 |
Volume Correlation
ZyVersa Therapeutics, Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
ZyVersa Therapeutics, Correlation - Currency/Commodity
ZyVersa Therapeutics, Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-10 400.00 (0.00 %) |
EPS: | $-1 008.15 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-10 400.00 (0.00 %) |
EPS: | $-1 008.15 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-10 400.00 (0.00 %) |
EPS: | $-2 925.42 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.890 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
ZyVersa Therapeutics,
ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It engages in the development of VAR 200, a cholesterol efflux mediator to treat focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney disease; and IC 100, a novel inflammasome ASC inhibitor for treatment of multitude of inflammatory diseases. ZyVersa Therapeutics, Inc. is headquartered in Weston, Florida.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators